Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.

Sethi S, Sethi R, Eschberger K, Lobbins P, Cai X, Grant BJ, Murphy TF.

Am J Respir Crit Care Med. 2007 Aug 15;176(4):356-61.

PMID:
17478618
2.

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.

Sethi S, Evans N, Grant BJ, Murphy TF.

N Engl J Med. 2002 Aug 15;347(7):465-71.

3.

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA.

Thorax. 2002 Sep;57(9):759-64.

4.

Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease.

Desai H, Eschberger K, Wrona C, Grove L, Agrawal A, Grant B, Yin J, Parameswaran GI, Murphy T, Sethi S.

Ann Am Thorac Soc. 2014 Mar;11(3):303-9. doi: 10.1513/AnnalsATS.201310-350OC.

PMID:
24423399
5.

Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD.

Garcha DS, Thurston SJ, Patel AR, Mackay AJ, Goldring JJ, Donaldson GC, McHugh TD, Wedzicha JA.

Thorax. 2012 Dec;67(12):1075-80. doi: 10.1136/thoraxjnl-2012-201924.

PMID:
22863758
6.

Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD.

Parameswaran GI, Sethi S, Murphy TF.

Chest. 2011 Sep;140(3):611-7. doi: 10.1378/chest.10-2760.

7.

Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.

Sethi S, Wrona C, Eschberger K, Lobbins P, Cai X, Murphy TF.

Am J Respir Crit Care Med. 2008 Mar 1;177(5):491-7.

PMID:
18079493
8.

[The role of macrolides in treatment of exacerbations of chronic obstructive pulmonary disease].

Targowski T, Jahnz-Rózyk K.

Pol Merkur Lekarski. 2010 Apr;28(166):311-4. Review. Polish.

PMID:
20491344
9.

Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.

Parameswaran GI, Wrona CT, Murphy TF, Sethi S.

BMC Infect Dis. 2009 Nov 15;9:178. doi: 10.1186/1471-2334-9-178.

10.

Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.

Barker BL, Haldar K, Patel H, Pavord ID, Barer MR, Brightling CE, Bafadhel M.

Chest. 2015 Jan;147(1):46-55. doi: 10.1378/chest.14-0764.

12.

Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response.

Murphy TF, Brauer AL, Grant BJ, Sethi S.

Am J Respir Crit Care Med. 2005 Jul 15;172(2):195-9.

13.

Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.

Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, Zalacaín R, Morera J, Torres A.

Arch Intern Med. 2005 Apr 25;165(8):891-7.

PMID:
15851640
14.

[The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].

Dacydchenko SV, Bova AA.

Klin Med (Mosk). 2007;85(5):10-5. Review. Russian.

PMID:
17665597
15.

Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers.

Chin CL, Manzel LJ, Lehman EE, Humlicek AL, Shi L, Starner TD, Denning GM, Murphy TF, Sethi S, Look DC.

Am J Respir Crit Care Med. 2005 Jul 1;172(1):85-91.

16.

Human rhinovirus infection during naturally occurring COPD exacerbations.

George SN, Garcha DS, Mackay AJ, Patel AR, Singh R, Sapsford RJ, Donaldson GC, Wedzicha JA.

Eur Respir J. 2014 Jul;44(1):87-96. doi: 10.1183/09031936.00223113.

17.

Bacteria and exacerbations of chronic obstructive pulmonary disease.

Anthonisen NR.

N Engl J Med. 2002 Aug 15;347(7):526-7. No abstract available.

PMID:
12181408
18.

Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.

Murphy TF, Brauer AL, Schiffmacher AT, Sethi S.

Am J Respir Crit Care Med. 2004 Aug 1;170(3):266-72.

PMID:
15117742
19.

Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.

Bathoorn E, Liesker JJ, Postma DS, Koëter GH, van der Toorn M, van der Heide S, Ross HA, van Oosterhout AJ, Kerstjens HA.

Int J Chron Obstruct Pulmon Dis. 2009;4:101-9.

20.

[Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].

Saldías PF, Díaz PO, Dreyse DJ, Gaggero BA, Sandoval AC, Lisboa BC.

Rev Med Chil. 2012 Jan;140(1):10-8. doi: /S0034-98872012000100002. Spanish.

Items per page

Supplemental Content

Support Center